Thursday, 22 February 2024

 

 

LATEST NEWS Sukhvinder Singh Sukhu Unveils Updated Land Code 2 Day Workshop On Recent Advances in Mathematics held at PEC Punjab Cabinet Schedules Budget Session and Approves Ex-Gratia for Martyred Volunteer VIT-AP University Unveils V-TAPP 2024: A Spectacular Technical Fest for Students Punjab Police Cracks Down on International Online Job Fraud Racket, Arrests Four in Assam DC Sakshi Sawhney reviews working of Society for Prevention of Cruelty to Animals Police personnel thank CM Sukhvinder Singh Sukhu for increase in their diet money Lovely Professional University Tops Indian Patent Filings, Surpassing IITs Sukhvinder Singh Sukhu Launches Pioneering 'International Tour for Teachers' Initiative R Madhavan New Movie 2024 - R Madhavan Must Awaited Movie Shaitan Trailer Launch on YouTube. A Horror SAGA With Ajay Devgan Bharat Takhtani Net Worth 2024: Exploring the Wealth of Esha Deol's Ex Husband DC Srinagar conducts late night inspection of various ongoing construction sites DC Ramban, SSP traffic inspects road clearance work on NH-44 DC reviews progress achieved under District Capex 2023-24 in Udhampur DC takes stock of patient care services at CHC Ramgarh ahead of External assessment DC Rajouri interacts with workers at Moughla Coal Mine Stage set for Kishtwar Idol 2.0: A Platform to promote Local Talent Dr. Abid reviews functioning of JKMSCL DC Bandipora visits Business Unit of Shaheena Begum International Mother Tongue Day: Dogri poetry recitation organized at GDC Marh DC reviews patient care services in Govt Medical College and Hospital Doda

 

Covid jabs won't raise immunity in organ transplant patients: Study

Coronavirus, COVID 19, Novel Coronavirus, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Health, Study, New York, Research, Researchers, World News, Journal of the American Medical Association, JAMA
Listen to this article

Web Admin

Web Admin

5 Dariya News

New York , 09 May 2021

Patients, who had organ transplants, remain vulnerable to Covid-19 infections even after a second vaccine dose, finds a study that urges people who are immunocompromised to strictly adhere to wearing masks, and maintain physical distancing, even after vaccination.The study, led by researchers at Johns Hopkins University in the US, showed that after two doses of Moderna or Pfizer-BioNTech vaccine against SARS-CoV-2 -- the virus that causes Covid 19, just 54 per cent people who have received solid organ transplants produced sufficient antibodies. The findings are published in the Journal of the American Medical Association (JAMA)."Transplant recipients should not assume that two vaccine doses guarantee sufficient immunity against SARS-CoV-2 any more than it did after just one dose," said Dorry Segev, Professor of Surgery and Epidemiology at the Johns Hopkins School of Medicine."Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict Covid-19 safety precautions, even after vaccination," added lead author Brian Boyarsky, surgeon at the varsity.

People who receive solid organ transplants (such as hearts, lungs and kidneys) often must take drugs to suppress their immune systems and prevent rejection. Such regimens may interfere with a transplant recipient's ability to make antibodies to foreign substances, including the protective ones produced in response to vaccines, the researchers said.The study evaluated this immunogenic response following vaccination from either Moderna or Pfizer-BioNTech in 658 transplant recipients, none of whom had a prior diagnosis of Covid-19, between December 16, 2020, and March 13, 2021.The team found that only 98 of the 658 study participants -- 15 per cent -- had detectable antibodies to SARS-CoV-2 at 21 days after the first vaccine dose.At 29 days following the second dose, the number of participants with detectable antibodies rose to 357 out of 658 -- 54 per cent. After both vaccine doses were administered, 301 out of 658 participants -- 46 per cent -- had no detectable antibody at all while 259 -- 39 per cent -- only produced antibodies after the second shot.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Health , Study , New York , Research , Researchers , World News , Journal of the American Medical Association , JAMA

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD